New hydrogel aims to stop radiation burns in breast cancer patients
NCT ID NCT05079763
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a hydrogel made from bacterial cellulose and coconut oil monolaurin to prevent severe skin reactions in Filipino women with breast cancer undergoing radiation therapy. About 54 participants will apply either the hydrogel or a placebo cream daily. The goal is to see if the hydrogel reduces the chance of high-grade skin burns, which can disrupt treatment and lower quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Bacterial cellulose-monolaurin hydrogel
What this could lead to
If it works, this could offer a simple, affordable way to prevent severe skin burns during radiation therapy, improving quality of life and treatment adherence.
What could go wrong
This is a small pilot study with only 54 participants, so results may not apply to everyone. The hydrogel is compared to a placebo cream, and it may not be more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hypofractionated vs Conventional Radiotherapy in NCT07084519
- Pertuzumab, Trastuzumab, Nab-Paclitaxel for HER2 NCT01730833
- Carboplatin for Triple-Negative Breast Cancer (NCT02488967)
- MRI Safety in Breast Tissue Expanders (NCT04769960)
- Pembrolizumab & Decitabine for HER2-Negative Bre NCT02957968
- Saline Soaks for Radiation Skin Rash Trial (NCT07553260)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Philippine General Hospital
RECRUITINGManila, 1000, Philippines
Contact Email: •••••@•••••